SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001193125-17-274393
Filing Date
2017-08-31
Accepted
2017-08-31 16:31:32
Documents
5

Document Format Files

Seq Description Document Type Size
1 424(B)(3) d442134d424b3.htm 424B3 479379
2 GRAPHIC g442134g0817071753404.jpg GRAPHIC 3156
3 GRAPHIC g442134g0817071753575.jpg GRAPHIC 50221
4 GRAPHIC g442134g0817071753825.jpg GRAPHIC 46659
5 GRAPHIC g442134g0817071754184.jpg GRAPHIC 4375
  Complete submission text file 0001193125-17-274393.txt   624785
Mailing Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752
Business Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752 (508) 767-3861
RXi Pharmaceuticals Corp (Filer) CIK: 0001533040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-220062 | Film No.: 171063681
SIC: 2834 Pharmaceutical Preparations